Skip to main content
. 2019 Mar-Apr;24(2):166–171. doi: 10.5863/1551-6776-24.2.166

Table.

Patient Details

Patient* PWS Sex (Race) Age (yr) Body Mass Index, kg/m2 (% Body Fat) Pitolisant Dosage (mg/day)
Before Pitolisant After Pitolisant
A Deletion Male (Caucasian) 12 16.4 (18.5) 15.2 (19.5) 4.5–27
B Uniparental disomy Female (Caucasian) 10 20 (30.2) 22.5 (31.4) 4.5–27
C Deletion Female (Caucasian) 15 23.1 (not available) 23.6 (not available) 4.5–31.5

*All children received nightly growth hormone injections.

At initiation of treatment with pitolisant, Patient C also received escitalopram, buspirone, risperidone, levoxythyroxine, and estradiol.